ACLX241220P70000
- 1.25
- 0.000.00%
Arcellx Newsroom
Arcellx, Inc. Reports Q3 2024 Earnings Highlights
Scotiabank Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $133
Are You Looking for a Top Momentum Pick? Why Arcellx, Inc. (ACLX) Is a Great Choice
Stifel Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $122
Truist Financial Maintains Arcellx(ACLX.US) With Buy Rating, Cuts Target Price to $134
Arcellx(ACLX.US) Director Sells US$5.97 Million in Common Stock
NASDAQ New 52-Week Highs And Lows
Truist Financial Maintains Arcellx(ACLX.US) With Buy Rating, Announces Target Price $136
Express News | Arcellx Inc : Truist Securities Raises Target Price to $136 From $87
Scotiabank Maintains Arcellx(ACLX.US) With Buy Rating, Raises Target Price to $133
Scotiabank Remains a Buy on Arcellx Inc (ACLX)
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $105 to $122
Express News | Rami Elghandour Reports 5.0% Stake in Arcellx Inc as of November 3, 2024- SEC Filing
Arcellx Is Maintained at Buy by HC Wainwright & Co.
Is Arcellx (ACLX) Outperforming Other Medical Stocks This Year?
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $111 to $115
Express News | Needham Maintains Buy on Arcellx, Raises Price Target to $105
Express News | Arcellx Inc : Piper Sandler Raises Target Price to $115 From $91
Arcellx | 10-Q: Q3 2024 Earnings Report
Arcellx | 8-K: Arcellx Provides Third Quarter 2024 Financial Results and Business Highlights